Toxicity analysis of capecitabine/temozolomide in NETs.
Volume: 38, Issue: 15_suppl, Pages: 4614 - 4614
Published: May 20, 2020
Abstract
4614 Background: The capecitabine/temozolomide regimen has significant activity in advanced NETs. Concerns exist regarding risk of opportunistic infections and long-term myelotoxicity. Analysis of large patient cohorts is needed for evaluation of rare toxicities and for assessment of risk factors. Methods: Retrospective study of all patients with advanced neuroendocrine neoplasms seen at the Moffitt Cancer Center between 1/2008 and 6/2019 who...
Paper Details
Title
Toxicity analysis of capecitabine/temozolomide in NETs.
Published Date
May 20, 2020
Journal
Volume
38
Issue
15_suppl
Pages
4614 - 4614
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History